Insider Trading History of Atlas Venture Associates Vi, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Atlas Venture Associates Vi, L.p. since 2006. The trader's CIK number is 1292359. At the time of the last reporting, Atlas Venture Associates Vi, L.p. was the Officer of Helicos Biosciences Corp. (stock ticker symbol HLCS). Also see all insider trading activities at Helicos Biosciences Corp.

Note that in the past Atlas Venture Associates VI, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Helicos Biosciences Corp (HLCS) by Atlas Venture Associates Vi, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 HLCS 333,333 $2,999,997 0 $0 0 $0

Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Atlas Venture Associates Vi, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 ALNY 0 $0 183,000 $2,729,523 0 $0


Insider trading activities at 2 companies by Atlas Venture Associates Vi, L.p.:

1. Helicos Biosciences Corp (HLCS)

2. Alnylam Pharmaceuticals, Inc. (ALNY)

Table 1. Insider trading of Helicos Biosciences Corp (HLCS) by Atlas Venture Associates Vi, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-05-30 HLCS Buy 333,333 9.00 2,999,997

Table 2. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Atlas Venture Associates Vi, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-02-24 ALNY Sale 120,000 14.80 1,775,640
2006-02-23 ALNY Sale 63,000 15.14 953,883

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atlas Venture Associates Vi, L.p. (Officer of Helicos Biosciences Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.